ARTICLE | Clinical News
Meloxicam regulatory update
November 9, 2015 8:00 AM UTC
FDA approved an NDA from Iroko for Vivlodex meloxicam to treat osteoarthritis (OA) pain. The product is a low-dose formulation of the NSAID meloxicam that uses SoluMatrix Fine Particle technology. ...